Chang, William H.
Brigham and Women's Hospital · Novartis (Switzerland) · Harvard University · Baylor College of Medicine · Universidade Federal de São Paulo
2 papers on CoChat
Most cited papers
- Verified
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine
Atherosclerosis and Cardiovascular DiseasesLipoproteins and Cardiovascular Health
Cited by 9,482
- Verified
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Ridker, P. M., MacFadyen, J. G., Thuren, T., Everett, B. M., Libby, P., Glynn, R. J., Ridker, P., Lorenzatti, A., Krum, H., Varigos, J., et al. (2017) · The Lancet
Inflammasome and immune disordersInflammatory Biomarkers in Disease Prognosis
Cited by 1,344
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free